Regeneca Worldwide, a division of VivaCeuticals, Inc. is conducting a nationwide recall of its entire line of herbal and dietary supplement products pursuant to a Consent Decree entered by the federal court for the Central District of California. This recall applies to all products manufactured a...
Regeneca Worldwide has been ordered to cease operations by the Department of Justice, which filed a consent decree of permanent injunction against the company and its CEO, Matthew Nicosia, alleging that they violated the Federal Food, Drug and Cosmetic Act (FDCA) by manufacturing and distributing...
Cottonwood Heights, UT June 11, 2015 -- Regeneca Worldwide has entered into an exclusive distribution agreement with VE Science Technologies LLC, the creators of the CardioMap heart screening and monitor device, for the network marketing industry. 'We are very excited about this deal, as the dist...
Cottonwood Heights, UT May 14, 2015 -- Regeneca Worldwide has concluded their search for a new President and are pleased to announce that Mr. Trent Staggs will now lead the company in this role. 'We are thrilled to have Trent Staggs join the Regeneca team and lead the company's operations,' said ...
Inc. Las Vegas, NV is conducting a voluntary nationwide recall of its RegenESlim appetite control dietary supplement from lot # EX0616R15814 and lot #11414RE5516 because FDA analysis confirmed the presence of DMAA. DMAA is also known as 1,3-dimethylamylamine, methylhexanamine, or geranium extract...
Irvine, CA -- The FDA sent Regeneca, Inc. a letter informing it that supplements containing DMAA (1,3-dimethylamylamine), such as the company's product RegeneSlim, cannot be legally marketed in the United States without the submission of a new dietary ingredient (NDI) notification to FDA. Accordi...
IRVINE, Calif., Feb 24, 2012 -- Regeneca, Inc. announced today that it is conducting a voluntary nationwide recall of all lots of single capsule packet RegenErect, labeled as a dietary supplement. The company, through independent lab analysis has confirmed the presence of Tadalafil making these p...
February 10, 2012 - Regeneca, Inc. announced today that it is conducting a voluntary nationwide recall of RegenArouse, Lot Number 130100, because FDA lab analysis has confirmed the presence of Tadalafil making these products unapproved new drugs. Tadalafil is an FDA-approved drug used as treatmen...
Regeneca has released a letter to its shareholders and distributors that reviews the past year and discusses plans for 2012. Highlights of the letter include: "Our pre-launch was successful and resulted in a dramatic increase in sales in the months of February, March and April...As we were prepar...
IRVINE, Calif., Nov 21, 2011 -- Regeneca(TM), Inc. today announced that Regeneca's mobile technology is the first to market of its kind in the industry. Regeneca launched its mobile technology which allows distributors to post infomercials to their websites and to transact through a mobile device...